- Breast
- Lung
- Hematologic Oncology
- Gastrointestinal
- Genitourinary
- General Oncology
- Sarcoma
- Skin
- Head & Neck
- Event
Playback speed
10 seconds
Ph-like ALL Should Be Treated as the Other B ALL After Demonstration of the Right Target and Best Trial / Registry Context
19 views
December 13, 2019
Comments 0
Login to view comments.
Click here to Login
Hematologic Oncology